You might think that legendary sci-fi author Arthur C. Clarke would've adored the Star Trek franchise, but that wasn't ...
A Space Odyssey, Gattaca, and Primer are incredible feats of filmmaking that remain compelling and flawless throughout.
Astronomy on MSN
June 23, 2015: 60,000 orbits for Mars Odyssey
NASA’s Mars Odyssey spacecraft completed its 60,000th orbit of the Red Planet on June 23, 2015. When Odyssey launched in ...
NASA wants to send an ambitious fleet of helicopters to soar through Martian skies—but scientists fear the endeavor could ...
Stanley Kubrick’s 1968 sci-fi masterpiece 2001: A Space Odyssey is the subject of a major new documentary project from a production team that includes Oscar-winning producer and studio head Mike ...
A veteran spacecraft has sniffed the Martian atmosphere for the last time. More than a decade after the MAVEN orbiter arrived at Mars and six months after it unexpectedly went quiet, NASA has ...
They call it the Mars Atmosphere and Volatile Evolution, or MAVEN, for short, and it's the first spacecraft dedicated to the study of the Martian atmosphere and its evolution. Or, should I say, was, ...
Tickets for Universal’s $250M Christopher Nolan feature take of Homer’s Odyssey went on sale today, but only for PLF (Premium Large Format) showtimes. Deadline has confirmed that the wait on AMC sites ...
Well, it seems securing tickets for Christopher Nolan‘s upcoming epic The Odyssey turned into its own arduous journey. On Thursday, as tickets went on sale for special formats like IMAX and PLF, ...
NASA will begin to decommission Maven, a Mars orbiter, which unexpectedly went silent in December 2025 after more than a decade of operations at the Red Planet. Credit: Lockheed Martin A healthy NASA ...
Christopher Nolan's The Odyssey won't be three hours long... but it will be pretty dang close. IMAX and AMC Theatres both revealed the runtime for Nolan's adaptation of the Greek epic and it clocks in ...
Odyssey Therapeutics has become the latest biotech to voyage to the public markets via an upsized $304 million IPO this morning. The autoimmune- and inflammatory-disease-focused company first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results